ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
17 announcements with these filters
Promoter entity Nirani Holdings Private Limited acquired 1,52,201 shares of TruAlt Bioenergy Limited worth Rs. 6.69 Crore via open market, increasing stake to 2.11%.
Nirani Holdings, part of Trualt Bioenergy's promoter group, pledged 14 lakh equity shares valued at ₹58.10 Crore.
TruAlt Bioenergy Limited reported the creation of a pledge on 14,00,000 equity shares held by promoter entity Nirani Holdings Private Limited.
TruAlt Bioenergy's Board commented on a ₹0.05 Cr exchange fine for Listing Regulation non-compliance. The company appointed a Woman Independent Director and paid the penalty.
Trualt Bioenergy Limited will acquire an additional stake in its subsidiary, Leafiniti Bioenergy Private Limited, for ₹21.42 Crore to maintain its proportionate shareholding.
TruAlt Bioenergy will invest Rs. 8.27 Crore to acquire additional equity shares in its subsidiary, TruAlt Sumi Gas Private Limited, to support growth objectives.
Trualt Bioenergy Limited has appointed Dr. Sarvamangala R. Patil as a Non-Executive Independent Director. This board-level appointment adds expertise in biotechnology, sustainability, and industrial development.
TruAlt Bioenergy approved investments totaling ₹29.69 Crore in two subsidiaries, Leafiniti Bioenergy and TruAlt Sumi Gas, to support their expansion plans.
Nirani Holdings, a promoter group entity, acquired 50,000 shares of TruAlt Bioenergy for Rs. 2.12 Crore from the open market.
Promoter group entity Nirani Holdings acquired 69,575 shares of TruAlt Bioenergy for Rs. 2.94 Crore. This increases the promoter group's total shareholding by 0.08%.
Promoter group entity Nirani Holdings Private Limited acquired 98,700 equity shares of TruAlt Bioenergy Limited worth ₹4.06 Crore from the open market.
TruAlt Bioenergy reported massive YoY growth in Q1 FY27, driven by a strategic pivot to multi-feed ethanol operations and inventory of lower-cost maize.
TruAlt Bioenergy reported strong Q1FY27 consolidated performance with Total Income of ₹641.41 Cr, up 96.4% YoY. Strategy centers on dual-feed ethanol integration and expansion into CBG and SAF verticals.
TruAlt Bioenergy Ltd reported revenue from operations of ₹626.9 Cr (+106.3% YoY) and net profit of ₹59.3 Cr (+1161.7% YoY) for Q1 FY27.
TruAlt Bioenergy reported FY26 standalone revenue of ₹1,704cr (down from ₹1,880cr) due to low OMC tender allocations. EBITDA margin improved to 19.81%. Transitioning to a diversified biofuels platform.
TruAlt Bioenergy reported FY26 consolidated revenue of ₹1813.96 Cr and PAT of ₹96.87 Cr. The company is transitioning to a multi-feed, year-round ethanol platform.
TruAlt Bioenergy Ltd reported revenue from operations of ₹595.5 Cr (-34.3% YoY) and net profit of ₹60.9 Cr (-45.5% YoY) for Q4 FY26.